Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Document Quarterly Report Document Transition Report Entity Interactive Data Current CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statement [Table] Statement [Line Items] Class of Stock [Axis] Series A Preferred Stock [Member] Cash and cash equivalents Prepaid expenses Other current assets Total current assets [Assets, Current] Other assets Total assets [Assets] Accounts payable Accrued liabilities Note Payable Total current liabilities [Liabilities, Current] Total liabilities [Liabilities] Commitments and contingencies; see Note 6 Preferred stock, undesignated, authorized 4,818,654 shares; See Note 7 Series A Preferred stock, par value $.0001, authorized 5,181,346 shares; issued and outstanding 210, as of March 31, 2024 and December 31, 2023, respectively Common stock, par value $.0001 per share; authorized 400,000,000 shares; issued and outstanding 1,958,245 as of March 31, 2024 and 298,281 as of December 31, 2023, respectively Additional paid-in capital Accumulated deficit Total stockholders' equity [Stockholders' Equity Attributable to Parent] Total liabilities and stockholders' equity [Liabilities and Equity] Common Stock, Par Value Common Stock, Shares Authorized Common Stock, Shares Issued Common Stock, Shares Outstanding Preferred Stock, Undesignated Shares Authorized Preferred Stock, Par Value Prefered Stock, Shares Issued Prefered Stock ,Shares Outstanding CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Operating expenses General and administrative Research and development Total operating expenses [Operating Expenses] Net operating loss [Operating Income (Loss)] Interest expense Other expense (income), net Net loss [Net Income (Loss) Attributable to Parent] Net loss per share, basic and diluted Weighted average number of common shares outstanding, basic and diluted CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (Unaudited) Equity Components [Axis] Preferred Stock Common Stock Additional Paid-In Capital Accumulated Deficit Balance, shares [Shares, Issued] Balance, amount Public offering sale of common stock and prefunded warrants, net, shares Public offering sale of common stock and prefunded warrants, net, amount Offering costs Exercise of pre-funded warrants for cash, shares Exercise of pre-funded warrants for cash, amount Exercise of pre-funded warrants, cashless, shares Exercise of pre-funded warrants, cashless, amount Exercise of warrants, cashless, shares Exercise of warrants, cashless, amount Stock split and fractional shares issued, shares Stock split and fractional shares issued, amount Compensation on options issued Net loss [Net loss] Balance, shares Balance, amount CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) CASH FLOWS FROM OPERATING ACTIVITIES Net Loss Adjustments to reconcile net loss to net cash used in operating activities Depreciation and amortization Interest on debt instrument Gain on sale of equipment Issuance and vesting of compensatory stock options and warrants Changes in operating assets and liabilities Accounts receivable, prepaid expenses and other assets [Increase (Decrease) in Accounts Receivable and Other Operating Assets] Accounts payable and accrued liabilities Net cash used in operating activities [Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities] CASH FLOWS FROM INVESTING ACTIVITIES Proceeds from sale of property and equipment Net cash provided by investing activities [Net Cash Provided by (Used in) Investing Activities] CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from issuance of common stock, warrants and pre-funded warrants Offering cost [Payments of Debt Issuance Costs] Proceeds from the exercise of warrants Payments on short-term note [Repayments of Notes Payable] Net cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Net change in cash and cash equivalents [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period DESCRIPTION OF BUSINESS DESCRIPTION OF BUSINESS Business Description and Basis of Presentation [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] BALANCE SHEET COMPONENTS BALANCE SHEET COMPONENTS Supplemental Balance Sheet Disclosures [Text Block] NOTE PAYABLE NOTE PAYABLE Debt Disclosure [Text Block] LEASE LEASE Leases of Lessee Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] STOCKHOLDERS EQUITY STOCKHOLDERS' EQUITY SUBSEQUENT EVENTS SUBSEQUENT EVENTS Subsequent Events [Text Block] Basis of Presentation Use Of Estimates Principles Of Consolidation Reverse Stock Split Cash And Cash Equivalents Cash Concentration Risk Liquidity And Capital Resources Stock-Based Compensation Equity-Based Payments to Non-Employees Warrants for Common Shares and Derivative Financial Instruments Loss Per Share Anti-dilutive Securities Accrued Liabilities Schedule of Warrants Activity Summary of vest based option outstanding Schedule of options outstanding Schedule of outstanding stock options Accumulated Deficit [Cumulative Earnings (Deficit)] Class of Warrant or Right [Axis] Pre-Funded Warrants To Purchase Common Stock [Member] Warrants To Purchase Common Stock[Member] Options To Purchase Common Stock[Member] Covertible Preferred Shares Outstanding [Member] Anti- Securities Dilutive Related Party Transactions By Related Party Axis Intra Fi Network [Member] Cash uninsured amount Federal Deposit Insurance Corporation insurance limits Total current assets [Capital Lease Obligations, Current] Working capital amount Cash resources Deposits Operating Costs Employee Related Total [Accounts Payable and Accrued Liabilities, Current] Depreciation expense Note Payable Related party Interest expense [Interest expense] Proceeds from issuance of note payable Interest rate on notes payable Note payable downpayment Monthly installment Lease Expense Annual Base Rent Increased Monthly installment [Monthly installment] Description of lease term Percentage Of Annual Increase In Rent Plan Name Axis Simdax License Agreement [Member] Grant paid to canadian authority Grant paid to authority Non-refundable commercialization milestone payment Warrants outstanding beginning [Class of Warrant or Right, Outstanding] Warrants issued Exercised Warrants outstanding ending Warrants,Weighted average exercise price beginning [Class of Warrant or Right, Exercise Price of Warrants or Rights] Weighted average exercise price, issued Weighted average exercise price, excercised Warrants, weighted average exercise price, ending Remaining contractual term Risk free interest rate Expected dividends Expected Volatility Grant under 2022 Plan Remaining contractual term Risk free interest rate Expected dividends Expected Volatility 2022 Stock Incentive Plan Options granted, beginning Options cancelled/forfeited Options granted, ending 2022 Plan Stock Options Number of shares, Options Outstanding, Beginning [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number] Number of shares outstanding ending balance Number of shares, Options Outstanding, cancelled/forfeited [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period] Weighted average exercise price, option outstanding, Beginning Balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price] Weighted average exercise price, Options cancelled/forfeited Weighted average exercise price, option outstanding, Ending Balance Grant under 2016 Plan [Member] Warrants,Weighted average exercise price, Options cancelled/forfeited Stock Options 1999 Plan [Member] Number of shares, Options Outstanding Options cancelled [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period] Warrants,Weighted average exercise price, Options cancelled Award Date Axis Award Type Axis Febuary 2024 Series A Stock Plan May 2022 Warrants Febuary 2023 Offering May 2022 Offering [Member] Pre-Funded Warrants [Member] July 2020 Offering [Member] February 2023 Offering [Member] 2016 Stock Incentive Plan Inducement Stock Options [Member] First Inducement Stock Options Second Inducement Stock Options Chief Medical Officer [Member] Febuary 2024 Offering Underwritten offering Exercise price Public offering sale of common stock and prefunded warrants, shares Anti- Securities Dilutive Common Stock, Shares Authorized Common Stock, Par Value Common Stock, Shares Outstanding Warrant To Purchase Of Unregistered Common Stock Common stock shares Warrnat purchase Offering Price Common stock warrant Gross proceeds form warrant Agent fees and direct offering expenses fair value allocated Pre-funded warrants Shares Warrant Estimated fair value Stock issued during period, shares Proceeds From Issuance Of Private Placement Warrant To Purchase Of Unregistered Common Stock, Value Pre-funded warrants issued Unrecognized Compensation Costs Compensation Expense Stock Option Award Granted Stock Options Description Estimated Fair Value Of The Inducement Stock Option Award Granted Risk-free interest rate Dividend Yield Volatility Factor Rate Expected Life Custom Element.